Paragon Care Limited (ASX: PGC) - ETF Exposure
Current share price for PGC : $0.135 0.005 (3.57%)+
Paragon Care Limited (PGC) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a provider durable medical equipment, medical devices, consumable medical products, and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia, New Zealand and Asia, as well as the distribution of pharmaceuticals, medical consumables, and complementary medicines to the Australian healthcare market.
PGC General Information +
| ASX Code | PGC |
| Website | N/A |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | 223 |
| PGC Share Price | $0.135 |
| Day High | $0.140 |
| Day Low | $0.130 |
| Last Close | $0.140 |
| PGC Share Price Movement | $0.01 ( 3.57% ) |
Prices as at 16:40, 3 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to PGC
Paragon Care Limited (PGC) is held across 1 ETF spanning strategies that include health care distributors exposure . Its weighting in those funds means performance can have an outsized influence - when PGC moves, funds like DACE that hold it can move with it.
For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to PGC , while the average exposure across all 1 ETF that hold it is around 0% .
Top ETF holdings
Last updated: ETF data and holdings as at 2 September 2026
Own PGC directly or through an ETF?
How does holding Paragon Care Limited (PGC) shares directly compare to ETFs that include it?
|
PGC Direct
|
DACE
ASX |
|
|---|---|---|
| Holdings | 1 company | 485 holdings |
| PGC Weight | 100% | 0% |
| Diversification | Single Stock | Broad |
| Annual Cost | Brokerage only | 0.28% p.a. |
| Approx. Yield | 0% | 2.95% |
| Star Ratings | - |  |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not PGC's direct yield. Annual cost uses each ETF's MER.
PGC Exposure on $10,000 investment
How a $10,000 investment in Paragon Care Limited (PGC) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Paragon Care Limited (PGC) | Direct share | $0.135 | -3.57% | -$357 | $9,643 |
| Dimensional Australian Core Equity (Managed Fund) (DACE) | Equity - Australia Strategy | $19.340 | -1.38% | -$138 | $9,862 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
Paragon Care Limited (PGC) ETFs
1 ETF hold Paragon Care Limited (PGC).
| ETF | PGC Weight | MER | Yield |
|---|---|---|---|
| Dimensional Australian Core Equity (Managed Fund) (DACE) | 0% | 0.28% | 2.95% |
Paragon Care Limited (PGC) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 0.6¢ | 100% | 18 Sep 2023 | 6 Oct 2023 | - | - | - |
| Result | 0.6¢ | 100% | 14 Mar 2023 | 5 Apr 2023 | - | - | - |
| HFResult | 0.6¢ | 100% | 12 Sep 2022 | 4 Oct 2022 | - | - | - |
See all dividends from Paragon Care Limited (PGC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Paragon Care Limited (PGC) price-sensitive announcements
PGC - FY26 Investor Presentation
Paragon Care Limited's FY26 results demonstrate revenue growth of 1.8% to $3.7 billion and
Paragon Care Limited (PGC)
26 Aug 2026 | 9:52 AM
26 Aug 2026 | 9:52 AM
PGC - FY26 Results Release
Paragon Care Limited announced its financial results for FY26, showing a revenue increase
Paragon Care Limited (PGC)
26 Aug 2026 | 9:50 AM
26 Aug 2026 | 9:50 AM
PGC - FY26 Appendix 4E and Preliminary Final Report
Paragon Care Limited's FY26 Appendix 4E and Preliminary Final Report highlights the compan
Paragon Care Limited (PGC)
26 Aug 2026 | 9:45 AM
26 Aug 2026 | 9:45 AM
PGC - Infinity Group Recovery and Earnings Update
Paragon Care Limited has provided an update on its financial exposure to the Infinity Reta
Paragon Care Limited (PGC)
1 Jun 2026 | 8:29 AM
1 Jun 2026 | 8:29 AM
Paragon Care Limited (PGC) Recent ASX Announcements
PGC Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$4.89 | -$0.30 | -118.20% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | $27.31 | $1.70 | 83.30% | 27.10 | 0.00 | 0.00% | 0.0% |
| 2024A | $8.38 | $0.90 | -56.50% | 27.80 | 0.00 | 0.00% | 0.0% |
PGC Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| EBOS Group Limited (EBO) | $3,554M | -0.0935 | -0.0364 | 0.1393 | 15.2853 | 15.8629 | 13.9231 | 5.74% | 4.43% | 5.02% |
| Paragon Care Limited (PGC) | $232M | -1.1818 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Sigma Healthcare Limited (SIG) | $31,283M | 0.1384 | 0.1631 | 0.1389 | 41.6923 | 35.8466 | 31.4750 | 1.48% | 1.68% | 1.88% |
PGC Directors
| Name | Position | Start Date |
|---|---|---|
| Mr David Keith Collins | Chief Executive Officer, Managing Director | 3 Jun 2024 |
| Ms Carmen Rose Riley | Chief Operating Officer, Executive Director | 3 Jun 2024 |
| Mr Michael Sapountzis | Company Secretary | 22 Nov 2024 |
| Mr Peter Andre Lacaze | Non-Executive Chairman, Non-Executive Director | 3 Jun 2024 |
| Mr Peter John Egglestone | Non-Executive Director | 20 Mar 2025 |
Paragon Care Limited (PGC) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 30 Jun 2026 | WALSTAB, John | Sell | Direct Shares | 6,000,000 | $0.130 | $780,000.000 |
| 30 Jun 2026 | WALSTAB, John | Buy | Indirect Shares | 6,000,000 | $0.130 | $780,000.000 |
| 29 Jun 2026 | EGGLESTONE, Peter | Buy | Indirect Shares | 200,000 | $0.135 | $26,980.000 |
See all changes in directors' interest & trades for Paragon Care Limited (PGC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PGC Management
| Name | Position |
|---|---|
| Marcus Crowe | Chief Financial Officer |
PGC Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Paragon Care Limited (PGC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 471,762,036 (28.50%) | Peter Andre Lacaze |
| 471,762,036 (28.50%) | David Keith Collins |
| 144,591,185 (8.73%) | John Walstab |
| 123,355,662 (7.45%) | Wilson Asset Management Group |
PGC Calendar of Events
| Date | Event |
|---|---|
| 25 August 2027 | Report (Prelim) |
| 24 February 2027 | Report (Interim) |
| 29 September 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
